Appointment-based medication synchronization
Citation: Nguyen E, Sobieraj DM. The impact of appointment-based medication synchronization on medication taking behaviour and health outcomes: A systematic review. Journal of Clinical Pharmacy and Therapeutics 2017; 42(4): 404-13
What is this? The COVID-19 pandemic is placing a strain on health services. Existing research on the effects of interventions that aim to improve patient adherence to medications, such as proactive repeat prescriptions through an Appointment-Based-Model (ABM), may provide useful information for policy makers.
In this systematic review the authors searched for comparative effectiveness studies of the impact of ABM for repeat prescriptions on medication-taking behaviours, clinical and cost outcomes. They restricted their searches to articles published in English and did the search in February 2017. They included 1 randomized trial, 1 quasi-experimental study and 3 observational studies; all from the USA.
What was found: ABM may improve medication adherence for patients with chronic conditions, although the randomized trial of patients with hypertension found no improvement in medication adherence in the ABM intervention group.
ABM might produce cost savings.
The effects of ABM on healthcare use, clinical outcomes and patient and provider satisfaction are uncertain.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.